Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
BACKGROUND: Despite limited and conflicting data on the use of hydroxychloroquine in patients with Covid-19, the U.S. Food and Drug Administration has authorized the emergency use of this drug when clinical trials are unavailable or infeasible. Hydroxychloroquine, alone or in combination with azithr...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-04-23
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1101/2020.04.16.20065920 https://hdl.handle.net/20.500.12663/1845 |